secwatch.observer — SEC 8-K summary
======================================

Issuer:     Imago BioSciences, Inc. (—)
CIK:        0001623715
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001193125-23-006137
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Merck completes $36/share acquisition of Imago BioSciences; shares delisted
---------------------------------------------------------------------------

- Merck acquired all shares of Imago for $36.00 cash per share via tender offer and merger on Jan 11, 2023.
- Approximately 89.2% of shares (31,307,028) were tendered, satisfying all conditions.
- Imago becomes wholly owned subsidiary of Merck; shares no longer listed on Nasdaq.
- Imago's board of directors replaced by Merck appointees; charter and bylaws amended.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/0001193125-23-006137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1623715/000119312523006137/d514174d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-006137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer